$33.00
-0.19 (-0.57%)
MYE News4 articles
Bristol Myers Unveils $2.3B Houston Facility for Flexible Drug Production
Bristol Myers Squibb (BMY) will build a $2.3 billion drug-manufacturing campus in Houston, supporting small molecules, biologics, and antibody-drug conjugates, with nearly 500 skilled jobs.
Bristol Myers Soars on AstraZeneca Takeover Talks, But Market Cap Math Raises Red Flags
Bristol Myers Squibb (BMY) surged 8% on AstraZeneca (AZN) merger speculation, but combined market cap fell $6.2B. Strong Q2 results and raised guidance bolster standalone case.
AstraZeneca slides on Bristol Myers tie-up talks; $5B value gap emerges
AstraZeneca shares dropped 5% on report of early merger talks with Bristol Myers Squibb, which gained 6% premarket. Combined market value fell about $5.2 billion.
Bristol Myers Squibb at Crossroads as AstraZeneca Merger Talks Surface
Bristol Myers Squibb shares rose 5.2% last week after strong Q2 earnings, but a reported $400B merger approach from AstraZeneca puts the stock in focus Monday.